Medical research

A blood test may help detect Alzheimer’s disease years before cognitive symptoms appear

ST20240821_202409200185/pixgeneric/Jason Quah
Generic pix of an elderly couple on a bus on 21 Aug, 2024.
ageing, population, old,

‘It’s still working’: More are living with cancer as era of targeted drugs takes hold

Menta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.

Covid-19 pandemic left 55,000 cancer cases undiagnosed across 7 nations, study finds

An estimated 16 per cent of expected cancer diagnoses across Australia, Canada, Denmark, Ireland, New Zealand, Norway and Britain were missing between April and December 2020.

J&J drug Erleada reduces risk of prostate cancer spread, death

Prostrate cancer patients who were on Erleada and hormone-blocking therapy went more than six years before requiring subsequent treatment.

Lung cancer patients on drug from China’s Akeso lived longer

The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.

Australian researchers teach brain cells to play ‘Doom’

Chief scientific and operations officer Brett Kagan looks at cortical and hippocampal cells on cell culture plates as they attempt to decode morse code, at Cortical Labs' Physical Containment Level 2 (PC2) laboratory in Melbourne.

Kenya approves US Ebola quarantine request as WHO chief heads to Congo

A UNICEF aid consignment for the Ebola outbreak caused by the Bundibugyo strain, sits at Bunia National Airport in Bunia, Ituri province, Democratic Republic of Congo, May 28, 2026. REUTERS/Gradel Muyisa Mumbere

GSK’s chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK has sought regulatory approval for the drug in the US, Japan, China and Europe.

Commentary

Preparing for a time when living to age 120 is commonplace

As societies continue to age, the writer says it is time to start thinking about the hard choices they may need to make.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.